The Nongenomic Effects of Progesterone in Repressing iNOS Activation through P38MAPK Pathways in Gonococci-Infected Polymorphonuclear Leukocytes and the Clinical Significance

Progesterone has nongenomic effects on inducible nitric oxide synthase(iNOS),which is mediated by mitogen activated protein kinase(MAPK)pathways.This effect is supposed to have some potential association with asymptomatic gonococcal infections in women by immunological depression.In this study,polym...

Full description

Saved in:
Bibliographic Details
Published inJournal of Huazhong University of Science and Technology. Medical sciences Vol. 30; no. 1; pp. 119 - 125
Main Author 陈嵘祎 涂亚庭 林加西 佘惟槟 李娟 吴志洪 许莉 陈宏翔
Format Journal Article
LanguageEnglish
Published Heidelberg Huazhong University of Science and Technology 01.02.2010
Guangdong Medical College,Zhanjiang 524023,China%Guangdong Medical College,Zhanjiang 524023,China%Department of Dermatology,Union Hospital,Tongli Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
Department of Dermatology,Union Hospital,Tongli Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Progesterone has nongenomic effects on inducible nitric oxide synthase(iNOS),which is mediated by mitogen activated protein kinase(MAPK)pathways.This effect is supposed to have some potential association with asymptomatic gonococcal infections in women by immunological depression.In this study,polymorphonuclear leukocytes(PMNs)challenged by gonococci were used to study the nongenomic effects of progesterone.The activation of iNOS was assessed by measuring [3H] L-arginine converses to [3H] L-citrulline,and t...
Bibliography:asymptomatic infection
R759.2
nongenomic effects
asymptomatic infection; gonococcus; inducible nitric oxide synthase; nongenomic effects; progesterone
42-1679/R
progesterone
gonococcus
inducible nitric oxide synthase
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1672-0733
1993-1352
DOI:10.1007/s11596-010-0122-4